PureCircle
20.1.2021 07:01:47 CET | Globenewswire | Press release
CHICAGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- PureCircle and Almendra reached an amicable settlement in a patent dispute in the United States relating to Almendra’s Steviarome® products and use thereof.
As of December 31, 2020, PureCircle and Almendra voluntarily resolved the litigation with all claims and counterclaims subsequently being dismissed.
As part of the settlement, Almendra signed a license agreement with PureCircle, which allows Almendra to continue selling its Steviarome® flavor ingredients worldwide. All other terms of the agreement remain confidential.
Enquiries:
Jackson Pillow, PureCircle Communications Manager
Email: Jackson.Pillow@purecircle.com
Phone: +1 (630) 256 8394
Kimberly Hunter, Almendra CFO
Email: Kimberly.H@almendra.com
Phone: +1 (708) 926-5403
About PureCircle
PureCircle is the leading producer and innovator of great-tasting stevia sweeteners and flavor modifiers for the global beverage and food industry. PureCircle combines advanced R&D with full vertical integration from farm to high-quality, great-tasting innovative stevia ingredients.
The Company collaborates with farmers who grow its proprietary stevia varieties, and with food and beverage companies which seek to improve their low- and no-calorie formulations using plant-based, non-GMO ingredients.
For more information, visit: www.purecircle.com
About Almendra
Almendra is a privately held natural sweetener and flavor ingredients company focused on the food and beverage industry’s need for great tasting natural, clean label solutions.
The company’s teamwork, innovation, IP and know-how allow it to develop industry-leading sweet taste solutions and to deliver flavors with modulating properties that address complex taste challenges of sugar reduced foods and beverages.
Headquartered in Singapore, Almendra manufactures in Thailand for sale to customers around the globe.
More information about Almendra is available at www.almendra.com
A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/3b6be781-a468-4f29-bd06-2bba8bd4ef8b
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
stevia plants
stevia plants
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
MoonLake Immunotherapeutics AG28.3.2026 20:00:00 CET | Press release
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Sanofi Winthrop Industrie28.3.2026 16:00:00 CET | Press release
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
Rocket Lab Corporation28.3.2026 11:39:53 CET | Press release
Rocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency
Vivoryon Therapeutics N.V.28.3.2026 07:00:00 CET | Press release
Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
